Skip to main content
. 2021 Jun 13;269(1):411–426. doi: 10.1007/s00415-021-10651-1

Table 4.

Non-motor symptom evaluation summary

Non-motor symptom Assessment group Assessment tools used to evaluate Frequency of use as an outcome measure (% of 237 total trials)
Neuropsychiatric QoL measures Sickness Impact Profile, SF-8/12/36, ALS-19, ALSSQOL, ALSAQ-5/40, ESAS, EQ-5D-5L, EQ-ED-3L, McGill 74 (31)
Symptom-specific ADI-12, HADS, Hamilton-Depression, Columbia Suicide
Cognitive QoL measures Sickness Impact Profile, ALS-19 16 (6.8)
Cognitive ACE-III, ALS-CBS, ECAS, MoCA, DSM Criteria (used as dementia diagnostic criteria), Verbal Fluency
Behavioural Quality of life and caregiver burden Sickness Impact Profile, ALS-19, Zarit Burden Interview, Caregiver Burden Inventory 37 (15)
Symptom-specific ALS-CBS, CNS-LS, ECAS, FTD Criteria, Emotionality Analogue Scale, FBI, Norris Scale
Pain Quality of life ALSSQOL, ESAS, EQ-5D-5L/3L, SF-12/36, McGill, ALSAQ-40 55 (23)
Pain Cramp Questionnaire, Numeric Rating Scale, Visual Analogue Scale
Sleep Quality of life ALSSQOL, Sickness Impact Profile, Edmonton Symptom Assessment Scale 12 (5)
Sleep Visual Analogue Scale, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale
Fatigue Quality of life ALSSQOL, Edmonton Symptom Assessment Scale 18 7.6)
Fatigue Visual Analogue Scale, Presence vs Absence Questions, Krupp Fatigue Severity Scale, Fatigue Severity Scale
Saliva ALS-FRS-(R), Visual Analogue Scale, ALSSQOL-R, CNS-BFS 182 (77)